Who owns Design Therapeutics Inc (DSGN)? Superinvestor holders
1 superinvestor of the 157 tracked here holds Design Therapeutics Inc (DSGN) in their latest 13F filing, a position of $38.8M. Julian and Felix Baker gives it the most weight: 0.19% of the reported portfolio. In their latest reported quarter, Julian and Felix Baker added.
Peter Kolchinsky sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 1 of 157
- Biggest holder
- Julian and Felix Baker, $38.8M
- Largest weight
- Julian and Felix Baker, 0.19%of their portfolio
- Combined value
- $38.8M
- Bought last quarter
- 1
- Sold last quarter
- 1
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Julian and Felix BakerBaker Bros. Advisors | 0.19% | $38.8M | 2.68M | ▲ Added 3.6% | +92.57K | Q2 2026 |
Sold out last quarter
- Peter Kolchinskywas $31.6M · Q2 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 0 | — | — | 0 | 0 |
| Q2 2026 | 157 | 1 | 2.68M | $38.8M | 1 | 1 |
| Q1 2026 | 157 | 2 | 5.56M | $59.1M | 2 | 0 |
| Q4 2025 | 157 | 2 | 3.69M | $34.7M | 2 | 0 |
| Q3 2025 | 157 | 2 | 2.19M | $16.5M | 1 | 0 |
| Q2 2025 | 157 | 1 | 1.71M | $5.8M | 0 | 1 |
| Q1 2025 | 156 | 1 | 1.74M | $6.7M | 0 | 0 |
| Q4 2024 | 156 | 1 | 1.74M | $10.8M | 0 | 0 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Julian and Felix Baker | · | 2.68M | 2.59M | 2.23M | 1.71M | 1.71M | 1.74M | 1.74M |
| Peter Kolchinsky | · | — | 2.97M | 1.46M | 475.7K | — | — | — |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own DSGN?
In their latest 13F filings: Julian and Felix Baker (0.19% of the portfolio, $38.8M).
Who bought DSGN last quarter?
Julian and Felix Baker (added 3.6%). “Last quarter” is each investor's latest reported quarter.
Who sold DSGN last quarter?
Sold out entirely: Peter Kolchinsky (was $31.6M).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Design Therapeutics Inc (DSGN)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/DSGN/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to DSGN by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.